Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients.
Maeda M, Saeki I, Sakaida I, Aikata H, Araki Y, Ogawa C, Kariyama K, Nouso K, Kitamoto M, Kobashi H, Sato S, Shibata H, Joko K, Takaki S, Takabatake H, Tsutsui A, Takaguchi K, Tomonari T, Nakamura S, Nagahara T, Hiraoka A, Matono T, Koda M, Mandai M, Mannami T, Mitsuda A, Moriya T, Yabushita K, Tani J, Yagi T, Yamasaki T. Maeda M, et al. Among authors: yagi t. Liver Cancer. 2020 Jan;9(1):50-62. doi: 10.1159/000502744. Epub 2019 Oct 22. Liver Cancer. 2020. PMID: 32071909 Free PMC article.
Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K. Tanaka S, et al. Among authors: yagi t. Int J Cancer. 2012 Dec 1;131(11):2537-46. doi: 10.1002/ijc.27575. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22488108 Free article.
Twist expression promotes migration and invasion in hepatocellular carcinoma.
Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Matsuo N, et al. Among authors: yagi t. BMC Cancer. 2009 Jul 18;9:240. doi: 10.1186/1471-2407-9-240. BMC Cancer. 2009. PMID: 19615090 Free PMC article.
Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis.
Nakanishi Y, Shiraha H, Nishina S, Tanaka S, Matsubara M, Horiguchi S, Iwamuro M, Takaoka N, Uemura M, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yagi T, Yamamoto K. Nakanishi Y, et al. Among authors: yagi t. BMC Cancer. 2011 Jan 4;11:3. doi: 10.1186/1471-2407-11-3. BMC Cancer. 2011. PMID: 21205319 Free PMC article.
Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Kataoka J, et al. Among authors: yagi t. Oncol Rep. 2016 May;35(5):2576-82. doi: 10.3892/or.2016.4681. Epub 2016 Mar 16. Oncol Rep. 2016. PMID: 26985715 Free PMC article.
Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
Sawahara H, Shiraha H, Uchida D, Kato H, Kato R, Oyama A, Nagahara T, Iwamuro M, Horiguchi S, Tsutsumi K, Mandai M, Mimura T, Wada N, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Watanabe M, Sakaguchi M, Takaki A, Nouso K, Yagi T, Nasu Y, Kumon H, Okada H. Sawahara H, et al. Among authors: yagi t. J Gastroenterol Hepatol. 2017 Oct;32(10):1769-1777. doi: 10.1111/jgh.13757. J Gastroenterol Hepatol. 2017. PMID: 28168749
[Corrigendum] Loss of Runt‑related transcription factor 3 induces resistance to 5‑fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Kataoka J, et al. Among authors: yagi t. Oncol Rep. 2017 Mar;37(3):1921. doi: 10.3892/or.2017.5419. Epub 2017 Feb 3. Oncol Rep. 2017. PMID: 28184917 Free PMC article.
Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency.
Yokomichi N, Nishida N, Umeda Y, Taniguchi F, Yasui K, Toshima T, Mori Y, Nyuya A, Tanaka T, Yamada T, Yagi T, Fujiwara T, Yamaguchi Y, Goel A, Kudo M, Nagasaka T. Yokomichi N, et al. Among authors: yagi t. Liver Cancer. 2019 Jul;8(4):239-254. doi: 10.1159/000490806. Epub 2018 Aug 21. Liver Cancer. 2019. PMID: 31602368 Free PMC article.
Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer.
Ako S, Kato H, Nouso K, Kinugasa H, Terasawa H, Matushita H, Takada S, Saragai Y, Mizukawa S, Muro S, Uchida D, Tomoda T, Matsumoto K, Horiguchi S, Nobuoka D, Yoshida R, Umeda Y, Yagi T, Okada H. Ako S, et al. Among authors: yagi t. Cancer Biol Ther. 2021 Dec 2;22(10-12):564-570. doi: 10.1080/15384047.2021.1980312. Epub 2021 Oct 10. Cancer Biol Ther. 2021. PMID: 34632919 Free PMC article.
Serum interferon-gamma-inducing factor/IL-18 levels in primary biliary cirrhosis.
Yamano T, Higashi T, Nouso K, Nakatsukasa H, Kariyama K, Yumoto E, Kobayashi Y, Yamamoto K, Iwagaki H, Yagi T, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T. Yamano T, et al. Among authors: yagi t. Clin Exp Immunol. 2000 Nov;122(2):227-31. doi: 10.1046/j.1365-2249.2000.01356.x. Clin Exp Immunol. 2000. PMID: 11091279 Free PMC article.
2,362 results